Description du projet
Une solution qui change la vie des patients atteints du syndrome de fatigue chronique
Le syndrome de fatigue chronique (SFC) est un trouble grave et complexe qui touche une part importante de la population mondiale. Il est souvent déclenché par une infection qui provoque un déséquilibre de la microflore intestinale. Malgré son origine plutôt commune, le SFC reste souvent non diagnostiqué. D’autre part, lorsqu’il est diagnostiqué, il n’est pas traité efficacement en raison d’un manque de mesures. Le projet Help4ME, financé par l’UE, entend combler cette lacune. Pour ce faire, il introduira un probiotique innovant, efficace pour corriger les déséquilibres de la microflore intestinale. Reposant sur la combinaison unique de cinq souches de lactobacilles dont l’efficacité a été démontrée, ce nouveau produit promet d’améliorer considérablement la qualité de vie des personnes souffrant du SFC.
Objectif
Let’s imagine being tired to the point where any activity causes weeks of weakness and pain. Common noises and daylight become an unbearable torture and a “brain fog” doesn’t let you think clearly. In spite of the tiredness, you wake up without being refreshed, if you can fall asleep at all. Days pass as well as doctors check-ups, and no one is able to tell you what is wrong. Finally, after few years of trying to pull yourself up, the answer is Chronic Fatigue Syndrome (CFS). Happy of the fact of being diagnosed, you quickly learn that it means that there are no measures able to cure you and chances of full recovery are only 5%.
Indeed, the reality of CFS patients’ life is tough and contrary to many beliefs it is not a rare disease. The world count of diagnosed CFS is estimated for up to 24 million cases and considered to be only 10% of the whole CFS population. Although frequently triggered by infection, cause of CFS is not yet known. Researches look for its source in the guts, which are inhabited by billions of microorganisms and form a complex ecosystem with profound impact on the whole body. Imbalance of gut microflora, damaged gut barrier functions and dysfunctional immune responses are known in CFS and shared with another disease - Irritable Bowel Syndrome (IBS), which frequently accompany CFS.
GutMagnific™ is an evidence-based probiotic scientifically designed and shown to be effective in correcting the gut microflora disbalance – a source of CFS and IBS symptoms. The novelty of the product lies in the unique combination of 5 lactobacilli strains with evidence-based efficacy and shows a life-changing promise to severely underserved population of CFS patients.
Champ scientifique
Programme(s)
Régime de financement
SME-1 - SME instrument phase 1Coordinateur
226 50 LUND
Suède
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.